Cargando…
Ultra-low-dose estrogen therapy for female hypogonadism
In females, endogenous estrogen secretion increases gradually before pubertal development. The benefits of low-dose estrogen therapy in patients with Turner syndrome were originally discussed by Ross et al. and Quigley et al. These seminal studies used ethinyl estradiol (EE2), starting at a dose of...
Autores principales: | Hasegawa, Yukihiro, Itonaga, Tomoyo, Ikegawa, Kento, Nishigaki, Satsuki, Kawai, Masanobu, Koga, Eri, Sakakibara, Hideya, Ross, Judith L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7160460/ https://www.ncbi.nlm.nih.gov/pubmed/32313372 http://dx.doi.org/10.1297/cpe.29.49 |
Ejemplares similares
-
Errata to “Ultra-low-dose estrogen therapy for female
hypogonadism”
por: Hasegawa, Yukihiro, et al.
Publicado: (2021) -
Pubertal induction in Turner syndrome without gonadal function: A possibility of earlier, lower-dose estrogen therapy
por: Hasegawa, Yukihiro, et al.
Publicado: (2023) -
Monitoring treatment in pediatric patients with 21-hydroxylase deficiency
por: Itonaga, Tomoyo, et al.
Publicado: (2023) -
Therapeutic needs from early childhood in four patients with 21-hydroxylase
deficiency harboring the P30L mutation on one allele
por: Itonaga, Tomoyo, et al.
Publicado: (2021) -
Fracture risk, underlying pathophysiology, and bone quality assessment in patients with Turner syndrome
por: Ikegawa, Kento, et al.
Publicado: (2022)